Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 3
2011 6
2012 6
2013 5
2014 4
2015 2
2016 3
2017 5
2018 6
2019 11
2020 10
2021 11
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Results by year
Filters applied: . Clear all
Page 1
Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial.
Mirza MR, Benigno B, Dørum A, Mahner S, Bessette P, Barceló IB, Berton-Rigaud D, Ledermann JA, Rimel BJ, Herrstedt J, Lau S, du Bois A, Herráez AC, Kalbacher E, Buscema J, Lorusso D, Vergote I, Levy T, Wang P, de Jong FA, Gupta D, Matulonis UA. Mirza MR, et al. Among authors: kalbacher e. Gynecol Oncol. 2020 Nov;159(2):442-448. doi: 10.1016/j.ygyno.2020.09.006. Epub 2020 Sep 25. Gynecol Oncol. 2020. PMID: 32981695 Clinical Trial.
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.
Monk BJ, Grisham RN, Banerjee S, Kalbacher E, Mirza MR, Romero I, Vuylsteke P, Coleman RL, Hilpert F, Oza AM, Westermann A, Oehler MK, Pignata S, Aghajanian C, Colombo N, Drill E, Cibula D, Moore KN, Christy-Bittel J, Del Campo JM, Berger R, Marth C, Sehouli J, O'Malley DM, Churruca C, Boyd AP, Kristensen G, Clamp A, Ray-Coquard I, Vergote I. Monk BJ, et al. Among authors: kalbacher e. J Clin Oncol. 2020 Nov 10;38(32):3753-3762. doi: 10.1200/JCO.20.01164. Epub 2020 Aug 21. J Clin Oncol. 2020. PMID: 32822286 Free PMC article. Clinical Trial.
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.
Duffaud F, Mir O, Boudou-Rouquette P, Piperno-Neumann S, Penel N, Bompas E, Delcambre C, Kalbacher E, Italiano A, Collard O, Chevreau C, Saada E, Isambert N, Delaye J, Schiffler C, Bouvier C, Vidal V, Chabaud S, Blay JY; French Sarcoma Group. Duffaud F, et al. Among authors: kalbacher e. Lancet Oncol. 2019 Jan;20(1):120-133. doi: 10.1016/S1470-2045(18)30742-3. Epub 2018 Nov 23. Lancet Oncol. 2019. PMID: 30477937 Clinical Trial.
Cancer de l’ovaire : la rechute précoce.
Pautier P, Kalbacher E, de la Motte Rouge T, Bonnetain F, Lesoin A. Pautier P, et al. Among authors: kalbacher e. Bull Cancer. 2017 May;104 Suppl 1:S32-S38. doi: 10.1016/S0007-4551(17)30160-1. Bull Cancer. 2017. PMID: 28625313 French.
COVID-19 vaccine acceptance among haemodialysis patients: a French survey.
Andrian T, Koppe L, Novel E, Massat M, Barba C, Ioriatti D, Barnel C, Villar E, Luce M, Guerraoui A, Mezaache S, Kalbacher E, Tournebize C, Fouque D, Chalencon E. Andrian T, et al. Among authors: kalbacher e. Clin Kidney J. 2021 Apr 28;14(8):1985-1986. doi: 10.1093/ckj/sfab084. eCollection 2021 Aug. Clin Kidney J. 2021. PMID: 34341684 Free PMC article. No abstract available.
[Relapse surveillance of patients with testicular germ cell tumor].
Orillard E, Klajer E, Kalbacher E, Joly F, David A, Hervé L, Viot J, Mouillet G, Barkatz J, Kleinclauss F, Thiery-Vuillemin A. Orillard E, et al. Among authors: kalbacher e. Bull Cancer. 2019 Oct;106(10):903-914. doi: 10.1016/j.bulcan.2019.06.006. Epub 2019 Sep 5. Bull Cancer. 2019. PMID: 31495441 Review. French.
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study.
Gernier F, Gompel A, Rousset-Jablonski C, Kalbacher E, Floquet A, Berton-Rigaud D, Tredan O, Alexandre J, Follana P, Zannetti A, Dohollou N, Grellard JM, Clarisse B, Licaj I, Ahmed-Lecheheb D, Fauvet R, Pautier P, Joly F. Gernier F, et al. Among authors: kalbacher e. Gynecol Oncol. 2021 Dec;163(3):598-604. doi: 10.1016/j.ygyno.2021.10.001. Epub 2021 Oct 11. Gynecol Oncol. 2021. PMID: 34649724 Free article.
70 results